FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: The incidence of IPEX syndrome is less than one in a million, and to date, more than seventy pathogenic mutations of FOXP3 have been described in over 200 patients (6, 7, 9–12).